Literature DB >> 11600552

Cerebrospinal fluid and plasma concentrations of leptin, NPY, and alpha-MSH in obese women and their relationship to negative energy balance.

S Y Nam1, J Kratzsch, K W Kim, K R Kim, S K Lim, C Marcus.   

Abstract

Leptin and its principal mediators, NPY and alpha-MSH are postulated to play a pivotal role in energy balance. To determine the possibility of the disturbance in neuropeptides in human obesity and their consequent changes in response to negative energy balance, we evaluated plasma and cerebrospinal fluid (CSF) leptin, NPY, and alpha-MSH levels in obese women before and after weight loss in comparison with normal control women. Subjects included 16 obese women [mean body mass index (BMI), 35.6 kg/m(2)] before and after weight loss induced by a 2-wk very low caloric diet (800 kcal/d) and 14 normal weight women (mean BMI, 20.4 kg/m(2)). The CSF to plasma leptin ratio in normal weight subjects was 2.3-fold higher than that in obese subjects. After weight loss in obese subjects, plasma leptin levels decreased by 40% and CSF levels decreased by 51%. There was a positive linear correlation between CSF and plasma leptin levels at baseline in obese subjects (r = 0.74, P < 0.05) and a positive logarithmic correlation in normal weight subjects (r = 0.89, P < 0.05) and in obese subjects after weight loss (r = 0.64, P < 0.05). The BMI was negatively correlated with the CSF to plasma leptin ratio (r = -0.86, P < 0.05) in all subjects. Neither the baseline plasma levels nor the baseline CSF levels of NPY were different between normal weight subjects and obese subjects. After weight loss, the CSF NPY level decreased significantly compared with baseline values in obese subjects. The alpha-MSH levels in plasma and CSF did not differ significantly from controls in obese subjects at baseline or after weight loss. Baseline CSF leptin level correlated with neither the baseline CSF NPY level nor the baseline CSF alpha-MSH level. In conclusion, this study demonstrated that the efficiency of brain leptin delivery is reduced in human obesity and central nervous system leptin uptake involves a combination of a saturable and an unsaturable mechanism. CSF NPY and alpha-MSH did not differ from controls in human obesity, and the CSF NPY level decreased significantly whereas alpha-MSH did not differ after weight loss in obese subjects compared with baseline. There was no significant correlation between CSF leptin and CSF NPY or alpha-MSH. This could be the result of leptin resistance present in human obesity and/or the more complex mechanisms involved in modulating appetite and regulating energy balance in human obesity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600552     DOI: 10.1210/jcem.86.10.7939

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Plasma neuropeptide Y levels in Chinese patients with primary insomnia.

Authors:  Qiaoting Huang; Jiwu Liao; Yaping Liu; Huajun Liang; Ping Ma; Jiyang Pan
Journal:  Sleep Breath       Date:  2014-09-27       Impact factor: 2.816

2.  Insulin and adipokine signaling and their cross-regulation in postmortem human brain.

Authors:  Hoau-Yan Wang; Ana W Capuano; Amber Khan; Zhe Pei; Kuo-Chieh Lee; David A Bennett; Rexford S Ahima; Steven E Arnold; Zoe Arvanitakis
Journal:  Neurobiol Aging       Date:  2019-08-20       Impact factor: 4.673

Review 3.  Recent advances in the understanding of how neuropeptide Y and α-melanocyte stimulating hormone function in adipose physiology.

Authors:  Steven L Shipp; Mark A Cline; Elizabeth R Gilbert
Journal:  Adipocyte       Date:  2016-07-13       Impact factor: 4.534

4.  Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.

Authors:  Wolfgang Lieb; Alexa S Beiser; Ramachandran S Vasan; Zaldy S Tan; Rhoda Au; Tamara B Harris; Ronenn Roubenoff; Sanford Auerbach; Charles DeCarli; Philip A Wolf; Sudha Seshadri
Journal:  JAMA       Date:  2009-12-16       Impact factor: 56.272

5.  Proopiomelanocortin, agouti-related protein, and leptin in human cerebrospinal fluid: correlations with body weight and adiposity.

Authors:  Gabrielle Page-Wilson; Kana Meece; Anne White; Michael Rosenbaum; Rudolph L Leibel; Richard Smiley; Sharon L Wardlaw
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-07-07       Impact factor: 4.310

6.  Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity.

Authors:  Bee K Tan; Manfred Hallschmid; Raghu Adya; Werner Kern; Hendrik Lehnert; Harpal S Randeva
Journal:  Diabetes       Date:  2011-09-16       Impact factor: 9.461

7.  Leptin levels are negatively correlated with 2-arachidonoylglycerol in the cerebrospinal fluid of patients with osteoarthritis.

Authors:  James Nicholson; Syed Azim; Mario J Rebecchi; William Galbavy; Tian Feng; Ruth Reinsel; Sabeen Rizwan; Christopher J Fowler; Helene Benveniste; Martin Kaczocha
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

8.  Alpha-Melanocyte-Stimulating Hormone and Agouti-Related Protein: Do They Play a Role in Appetite Regulation in Childhood Obesity?

Authors:  Aysel Vehapoğlu; Serdar Türkmen; Şule Terzioğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-12-18

9.  Lower cerebrospinal fluid/plasma fibroblast growth factor 21 (FGF21) ratios and placental FGF21 production in gestational diabetes.

Authors:  Bee K Tan; Kavitha Sivakumar; Muhammad F Bari; Manu Vatish; Harpal S Randeva
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

Review 10.  Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases.

Authors:  Keira A Markey; Maria Uldall; Hannah Botfield; Liam D Cato; Mohammed A L Miah; Ghaniah Hassan-Smith; Rigmor H Jensen; Ana M Gonzalez; Alexandra J Sinclair
Journal:  J Pain Res       Date:  2016-04-19       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.